Literature DB >> 35083736

Patient Experience Data for Medical Product Development: Opportunity Beyond Obligation.

Robyn T Carson1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35083736     DOI： 10.1007/s40271-021-00570-8

Source DB:  PubMed          Journal:  Patient        ISSN： 1178-1653            Impact factor:   3.883


× No keyword cloud information.
  8 in total

1.  The Role of Patient Experience in the Value Assessment of Complex Technologies - Do HTA Bodies Need to Reconsider How Value is Assessed?

Authors:  Grammati Sarri; Andreas Freitag; Boglarka Szegvari; Irina Mountian; Diana Brixner; Neil Bertelsen; Zoltán Kaló; Sheela Upadhyaya
Journal:  Health Policy       Date:  2021-03-25       Impact factor: 2.980

2.  A Randomized Clinical Trial Comparing the ELLIPTA and HandiHaler Dry Powder Inhalers in Patients With COPD: Inhaler-Specific Attributes and Overall Patient Preference.

Authors:  Kathryn A Collison; Pinal Patel; Andrew F Preece; Richard H Stanford; Raj K Sharma; Gregory Feldman
Journal:  COPD       Date:  2017-12-11       Impact factor: 2.409

3.  Utilizing the Patient Reported Outcomes Measurement Information System (PROMIS®) to increase referral to ancillary support services for severely symptomatic patients with gynecologic cancer.

Authors:  Gregory M Gressel; Shayan M Dioun; Michael Richley; David W Lounsbury; Bruce D Rapkin; Sara Isani; Nicole S Nevadunsky; D Y S Kuo; Akiva P Novetsky
Journal:  Gynecol Oncol       Date:  2019-03       Impact factor: 5.482

4.  Increasing Patient Involvement in Drug Development.

Authors:  Maria M Lowe; David A Blaser; Lisa Cone; Steve Arcona; John Ko; Rahul Sasane; Paul Wicks
Journal:  Value Health       Date:  2016-05-24       Impact factor: 5.725

5.  FDA Reported Use of Patient Experience Data in 2018 Drug Approvals.

Authors:  Cameron M Kieffer; Alexis Reisin Miller; Benjamin Chacko; Andrew S Robertson
Journal:  Ther Innov Regul Sci       Date:  2019-10-09       Impact factor: 1.778

Review 6.  The Case for the Use of Patient and Caregiver Perception of Change Assessments in Rare Disease Clinical Trials: A Methodologic Overview.

Authors:  Marielle G Contesse; James E Valentine; Tracy E Wall; Mindy G Leffler
Journal:  Adv Ther       Date:  2019-03-16       Impact factor: 3.845

7.  Enhancing the incorporation of the patient's voice in drug development and evaluation.

Authors:  Meghana Chalasani; Pujita Vaidya; Theresa Mullin
Journal:  Res Involv Engagem       Date:  2018-04-02

8.  Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review.

Authors:  Rosanne Janssens; Isabelle Huys; Eline van Overbeeke; Chiara Whichello; Sarah Harding; Jürgen Kübler; Juhaeri Juhaeri; Antonio Ciaglia; Steven Simoens; Hilde Stevens; Meredith Smith; Bennett Levitan; Irina Cleemput; Esther de Bekker-Grob; Jorien Veldwijk
Journal:  BMC Med Inform Decis Mak       Date:  2019-10-04       Impact factor: 2.796
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.